Lanthanum carbonate CAS 6487-39-4
It is suitable for the treatment of hyperphosphatemia in patients with end-stage renal disease.
|
(TREO):≥46.78
|
La2O3/TREO:≥99.95%
|
|
RE Impurities Content(%)
|
Non-RE Impurities Content(Max %)
|
|
CaO2: < 0.02
Y2O3: < 0.01 Pr6O11: < 0.01 Nd2O3 : < 0.001 Sm2O3: < 0.0005 |
Fe2O3: 0.002
SO42-: 0.017 CL-: 0.034 SiO2: 0.003 PbO: 0.002 CaO: 0.046 |
Write your message here and send it to us
